1. A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity‐related risk factors (COR‐II)12. (20th June 2013) Authors: Apovian, Caroline M.; Aronne, Louis; Rubino, Domenica; Still, Christopher; Wyatt, Holly; Burns, Colleen; Kim, Dennis; Dunayevich, Eduardo Journal: Obesity Issue: Volume 21:Number 5(2013:May) Page Start: 935 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Add‐on cannabidiol in patients with Dravet syndrome: Results of a long‐term open‐label extension trial. (18th August 2021) Authors: Scheffer, Ingrid E.; Halford, Jonathan J.; Miller, Ian; Nabbout, Rima; Sanchez‐Carpintero, Rocio; Shiloh‐Malawsky, Yael; Wong, Matthew; Zolnowska, Marta; Checketts, Daniel; Dunayevich, Eduardo; Devinsky, Orrin Journal: Epilepsia Issue: Volume 62:issue 10(2021) Page Start: 2505 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cannabidiol efficacy independent of clobazam: Meta‐analysis of four randomized controlled trials. (17th July 2020) Authors: Devinsky, Orrin; Thiele, Elizabeth A; Wright, Stephen; Checketts, Daniel; Morrison, Gilmour; Dunayevich, Eduardo; Knappertz, Volker Journal: Acta neurologica Scandinavica Issue: Volume 142:Number 6(2020) Page Start: 531 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Cannabidiol in conjunction with clobazam: analysis of four randomized controlled trials. (22nd October 2020) Authors: Gunning, Boudewijn; Mazurkiewicz‐Bełdzińska, Maria; Chin, Richard F. M.; Bhathal, Hari; Nortvedt, Charlotte; Dunayevich, Eduardo; Checketts, Daniel Journal: Acta neurologica Scandinavica Issue: Volume 143:Number 2(2021) Page Start: 154 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Long‐term safety and efficacy of add‐on cannabidiol in patients with Lennox–Gastaut syndrome: Results of a long‐term open‐label extension trial. (20th July 2021) Authors: Patel, Anup D.; Mazurkiewicz‐Bełdzińska, Maria; Chin, Richard F.; Gil‐Nagel, Antonio; Gunning, Boudewijn; Halford, Jonathan J.; Mitchell, Wendy; Scott Perry, Michael; Thiele, Elizabeth A.; Weinstock, Arie; Dunayevich, Eduardo; Checketts, Daniel; Devinsky, Orrin Journal: Epilepsia Issue: Volume 62:issue 9(2021) Page Start: 2228 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Sustained Treatment Response With Long-Term Valbenazine in Patients With Tardive Dyskinesia. (April 2023) Authors: Correll, Christoph U.; Lindenmayer, Jean-Pierre; Farahmand, Khody; Jen, Eric; Siegert, Scott; Dunayevich, Eduardo Journal: CNS spectrums Issue: Volume 28:Number 2(2023) Page Start: 240 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Time to onset of cannabidiol treatment effects in Dravet syndrome: Analysis from two randomized controlled trials. (15th July 2021) Authors: Madan Cohen, Jennifer; Checketts, Daniel; Dunayevich, Eduardo; Gunning, Boudewijn; Hyslop, Ann; Madhavan, Deepak; Villanueva, Vicente; Zolnowska, Marta; Zuberi, Sameer M. Journal: Epilepsia Issue: Volume 62:issue 9(2021) Page Start: 2218 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗